2026-03-06 The Microdose (Berkeley)

AtaiBeckley’s MDMA product could treat social anxiety; HHS Secretary Kennedy talks psychedelics on Rogan podcast; WV Senate and SD legislature pass Compass trigger bills

Plus: Pilot study uses psilocybin for post-treatment Lyme disease and Psychedelic-assisted therapy bill rejected then resurrected in Georgia

External link. We are not responsible for the content.

Read more ↗

More From The Microdose (Berkeley)

2026-04-20 The Microdose (Berkeley)

Can an LLM get high? 5 Questions with clinical neuroscientist Ziv Ben-Zion

Ben-Zion discusses how artificial intelligence mimics the psychedelic experience.

2026-04-17 The Microdose (Berkeley)

Scientists test if ketamine has antidepressant effects under anesthesia; France is the first to approve IV ketamine for severe suicidal crisis

Plus: New research on the role of trip sitters; Various state bills move to expand psychedelics research and access

2026-04-13 The Microdose (Berkeley)

Can you kill a bad trip?: 5 Questions for emergency physician Gregory Yates

Yates discusses experimental attempts to end a psychedelic trip early.

Latest News

2026-04-20 Psychedelics Today

Whitehouse Directs FDA, HHS and VA to Expand Psychedelic Research Pathways

The White House moved to accelerate federal handling of psychedelic drugs, including ibogaine, while leaving core app...

2026-04-20 DoubleBlind Magazine

5 Things We Learned at Psychedelic Culture 2026

Plus, ketamine addiction, DMT lasers, and plant medicine faeries [...] Read More... The post 5 Things We Learned at P...

2026-04-19 The Psychedelic Blog (Substack)

Global Altered States: The Storefront Psychedelic

This week’s Sunday Insider: inside a storefront where Psychedelics are no longer a journey…they’re a choice.

2026-04-19 Chemical Collective

Psychonautisme, Herbes et Suppléments

De nombreux aliments et compléments alimentaires courants contiennent des composés actifs qui interagissent avec la n...

2026-04-18 MAPS

MAPS Welcomes Federal Action to Advance Science-Driven Psychedelic Research and Policy

April 18, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) issued the following statements fro...

2026-04-17 Psychedelics Today

Op-Ed: Iboga, Ibogaine & 5-MeO-DMT: What gets missed when complex medicines are reduced to standard protocols

What gets lost when iboga is reduced to ibogaine, and complex care is reduced to protocol? In this op-ed, Paije West ...